Bacterial safety study of the production process of hemoglobin-based oxygen carriers

Abstract

Hemoglobin microparticles (HbMP) produced with a three-step procedure, including coprecipitation of hemoglobin with manganese carbonate, protein cross-linking, and dissolution of the carbonate template were shown to be suitable for application as artificial oxygen carriers. First preclinical safety investigations delivered promising results. Bacterial safety plays a decisive role during the production of HbMP. Therefore, the bioburden and endotoxin content of the starting materials (especially hemoglobin) and the final particle suspension are intensively tested. However, some bacteria may not be detected by standard tests due to low concentration. The aim of this study was to investigate how these bacteria would behave in the fabrication process. Biocidal effects are known for glutaraldehyde and for ethylenediaminetetraacetic acid, chemicals that are used in the fabrication process of HbMP. It was shown that both chemicals prevent bacterial growth at the concentrations used during HbMP fabrication. In addition, the particle production was carried out with hemoglobin solutions spiked with Escherichia coli or Staphylococcus epidermidis. No living bacteria could be detected in the final particle suspensions. Therefore, we conclude that the HbMP fabrication procedure is safe in respect of bacterial contamination.

Development of novel polymer haemoglobin based particles as an antioxidant, antibacterial and an oxygen carrier agents

“…During peptic digestion of bovine haemoglobin at a low degree of hydrolysis, Nedjar-Arroume et al identified and characterized 24 novel and remarkable antibacterial peptides 31 . Many studies reported the usage of haemoglobin with other materials in the development of several active antibacterial agents 32 – 34 .…”